Stanford preprint: CD19-CAR T cells clear EBV+ autoreactive B cells in autoimmune disease
ahandvanish · x · 2026-11-04
A new preprint from Stanford's Robinson Lab (led by Ya'el Courtney and Mahesh Pandit) shows CD19-CAR T-cell therapy resets the EBV+ autoreactive B cell repertoire in autoimmune disease — clearing cells that rituximab cannot, potentially explaining why only CAR-T produces lasting remission.
More from Research
- Library of Layers (LoL): Paper Proposes Adaptively Ordering Transformer Layers at Runtime — Thrumpwart · 2026-11-04
- Researchers Warn of 'Vibe Science': AI-Slop ICLR Submissions Full of Bold Claims, Broken Logic — IanArawjo · 2026-11-04
- TAMU professor releases 400+ page AI-assisted tutorial deck on generative models — ShuiwangJi · 2026-11-04
- DeepMind mafia seeding a new wave of AI for Science startups in the UK — ersatzben · 2026-11-04
- MIT CSAIL fixes small models by hand-editing weights — hype or old idea rebranded? — ziv_ravid · 2026-11-04
- Robots need failure data: learned sims handle rendering, MuJoCo keeps contact honest — chris_j_paxton · 2026-11-04